Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
ACELRX PHARMACEUTICALS INC (ACRX)
Sector: Healthcare; Industry: Drug Manufacturers—Specialty & Generic

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. The company's lead product candidate is DSUVIA, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-06-15 ADAMS ADRIAN Director Buy 100,000 $1.29 $128,900 No
2020-06-15 ADAMS ADRIAN Director Buy 100,000 $1.29 $128,900 No
2020-06-15 Angotti Vincent J. Chief Executive Officer Buy 7,547 $1.33 $10,035 No
2019-11-12 EDWARDS MARK G Director Buy 25,000 $1.78 $44,575 No
2019-11-11 Angotti Vincent J. Chief Executive Officer Buy 8,379 $1.79 $14,973 No
2019-08-26 EDWARDS MARK G Director Buy 15,000 $2.19 $32,806 No
2019-06-05 Angotti Vincent J. Chief Executive Officer Buy 5,000 $2.31 $11,550 No
2019-03-12 EDWARDS MARK G Director Buy 19,000 $2.99 $56,890 No
2019-02-28 ASADORIAN RAFFI Chief Financial Officer Buy 3,647 $2.81 $10,248 No
2019-02-28 Dasu Badri N Chief Engineering Officer Buy 9,206 $2.81 $25,869 No
2019-02-28 Angotti Vincent J. Chief Executive Officer Buy 3,234 $2.81 $9,088 No
2019-02-28 Hamel Lawrence G Chief Development Officer Buy 3,682 $2.81 $10,346 No
2019-02-28 Palmer Pamela P Chief Medical Officer Buy 840 $2.81 $2,360 No
2018-12-14 Angotti Vincent J. Chief Executive Officer Buy 3,610 $2.78 $10,024 No
2018-12-14 ASADORIAN RAFFI Chief Financial Officer Buy 5,000 $2.78 $13,883 No
2018-12-12 Angotti Vincent J. Chief Executive Officer Buy 10,000 $2.99 $29,890 No
2018-11-19 Palmer Pamela P Chief Medical Officer Buy 16,000 $3.07 $49,120 No
2018-11-15 EDWARDS MARK G Director Buy 20,700 $2.82 $58,376 No
2018-11-13 ASADORIAN RAFFI Chief Financial Officer Buy 5,000 $3.13 $15,646 No
2018-10-15 Hamel Lawrence G Chief Development Officer Sell 5,216 $5.00 $26,080 No
2018-10-15 Dasu Badri N Chief Engineering Officer Sell 28,351 $5.00 $141,755 No
2018-09-24 Hamel Lawrence G Chief Development Officer Sell 6,953 $4.50 $31,288 No
2018-08-07 EDWARDS MARK G Director Buy 5,300 $2.84 $15,063 No
2018-08-07 Angotti Vincent J. Chief Executive Officer Buy 10,000 $2.90 $28,950 No
2018-08-06 Palmer Pamela P Chief Medical Officer Buy 37,000 $2.75 $101,750 No
2018-08-06 ASADORIAN RAFFI Chief Financial Officer Buy 5,000 $2.75 $13,725 No
2018-06-05 EDWARDS MARK G Director Buy 5,000 $3.35 $16,735 No
2018-05-25 ASADORIAN RAFFI Chief Financial Officer Buy 5,000 $3.18 $15,922 No
2017-11-14 EDWARDS MARK G Director Buy 30,000 $1.90 $56,970 No
2017-11-13 ASADORIAN RAFFI Chief Financial Officer Buy 5,000 $1.94 $9,710 No

Insider Smart

PENN NATIONAL GAMING INC (PENN) - PENN took a deep dive from $36 to $5 due to the crash, anyone who was bold enough to pick up some shares in March or April could have made a 900% profit in 2 months. But bottom fishing is always easier said than done, if one took a safer bet and followed multiple insider buying around $18, a 100% profit is still impressive.

Insider Smart

CEDAR FAIR L.P. (FUN) - Another crash victim, Cedar Fair L.P. took a deep dive from $54 to $13, insiders were confidence and eagerly jumped in around $27. With insiders on your side, this would be an easy add and hold to get your cost under $20. Stock is about to breach $40 in the coming weeks.